Acute stroke: delays to presentation and emergency department evaluation.

PubWeight™: 1.77‹?› | Rank: Top 3%

🔗 View Article (PMID 9867880)

Published in Ann Emerg Med on January 01, 1999

Authors

R Kothari1, E Jauch, J Broderick, T Brott, L Sauerbeck, J Khoury, T Liu

Author Affiliations

1: Department of Emergency Medicine, University of Cincinnati Medical Center, OH, USA. rashmikant.kothari@uc.edu

Articles citing this

Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol (2008) 3.63

A multicentre observational study of presentation and early assessment of acute stroke. BMJ (2002) 2.01

A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int J Stroke (2009) 1.76

Racial disparities in tissue plasminogen activator treatment rate for stroke: a population-based study. Stroke (2011) 1.28

The role of ethnicity, sex, and language on delay to hospital arrival for acute ischemic stroke. Stroke (2010) 1.27

Current management of acute ischemic stroke. Part 1: Thrombolytics and the 3-hour window. Can Fam Physician (2001) 1.17

Understanding reasons for delay in seeking acute stroke care in an underserved urban population. Stroke (2011) 1.16

An educational multimedia campaign has differential effects on public stroke knowledge and care-seeking behavior. J Neurol (2008) 1.12

Prehospital notification by emergency medical services reduces delays in stroke evaluation: findings from the North Carolina stroke care collaborative. Stroke (2011) 1.08

Inter-rater reliability of data elements from a prototype of the Paul Coverdell National Acute Stroke Registry. BMC Neurol (2008) 1.08

Delay in presentation after an acute stroke in a multiethnic population in South london: the South london stroke register. J Am Heart Assoc (2012) 1.02

Early identification and delay to treatment in myocardial infarction and stroke: differences and similarities. Scand J Trauma Resusc Emerg Med (2010) 1.01

Methodology for a community-based stroke preparedness intervention: the Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities Study. Stroke (2014) 0.87

Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers. J Am Heart Assoc (2015) 0.84

Factors delaying hospital arrival of patients with acute stroke. Ann Indian Acad Neurol (2015) 0.83

Social network types and acute stroke preparedness behavior. Cerebrovasc Dis Extra (2011) 0.83

An evaluation of emergency medical services stroke protocols and scene times. Prehosp Emerg Care (2013) 0.82

Are in-Hospital Delays Important Obstacles in Thrombolytic Therapy Following Acute Ischemic Stroke? J Clin Neurol (2007) 0.82

Therapeutic hypothermia for acute brain injuries. Scand J Trauma Resusc Emerg Med (2015) 0.81

Stroke-Unit and emergency medical service: a 48-month experience in northern Italy. Neurol Sci (2012) 0.81

Therapeutics targeting Nogo-A hold promise for stroke restoration. CNS Neurol Disord Drug Targets (2013) 0.80

Symptom recognition of heart attack and stroke in nine European countries: a representative survey. Health Expect (2012) 0.80

[Avoiding time delay in acute stroke management. Data analysis of the Austrian Stroke Unit Registry]. Wien Med Wochenschr (2008) 0.78

Patient awareness and perception of stroke symptoms and the use of 911. J Stroke Cerebrovasc Dis (2014) 0.78

Predicting acute ischaemic stroke outcome using clinical and temporal thresholds. ISRN Neurol (2011) 0.77

Evaluation of the Recognition of Stroke in the Emergency Room (ROSIER) scale in Chinese patients in Hong Kong. PLoS One (2014) 0.77

Training emergency services' dispatchers to recognise stroke: an interrupted time-series analysis. BMC Health Serv Res (2013) 0.77

Time-critical neurological emergencies: the unfulfilled role for point-of-care testing. Int J Emerg Med (2010) 0.75

Candidates for thrombolytic treatment in acute ischaemic stroke--where are our patients in Hong Kong? J Accid Emerg Med (1999) 0.75

Factors preventing African Americans from seeking early intervention in the treatment of ischemic strokes. J Natl Med Assoc (2001) 0.75

Inter-rater reliability of a national acute stroke register. BMC Res Notes (2015) 0.75

Ethnicity and thrombolysis in ischemic stroke: a hospital based study in Amsterdam. BMC Neurol (2011) 0.75

Do clinical rehabilitation education programs really improve stroke-related knowledge? Am J Phys Med Rehabil (2008) 0.75

Race-Ethnic Disparities in Hospital Arrival Time after Ischemic Stroke. Ethn Dis (2017) 0.75

Disrupted mitochondrial genes and inflammation following stroke. Life Sci (2016) 0.75

Articles by these authors

The ABCs of measuring intracerebral hemorrhage volumes. Stroke (1996) 6.78

The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke (1998) 4.93

Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology (2006) 4.88

Ragweed immunotherapy in adult asthma. N Engl J Med (1996) 4.69

HIV infection is blocked in vitro by recombinant soluble CD4. Nature (1988) 4.58

Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke (1997) 4.55

Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke (1994) 4.45

Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med (2000) 4.33

Public perception of stroke warning signs and knowledge of potential risk factors. JAMA (1998) 4.21

The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med (1992) 3.56

Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med (1999) 3.54

Measuring the diaspora for virus-specific CD8+ T cells. Proc Natl Acad Sci U S A (2001) 3.51

Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol (2008) 3.32

Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke (1999) 2.85

Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med (1999) 2.82

Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region. Oncogene (2010) 2.73

Long-term mortality after intracerebral hemorrhage. Neurology (2006) 2.71

Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site. J Biol Chem (1985) 2.64

Interlaboratory comparison of ultrasonic backscatter, attenuation, and speed measurements. J Ultrasound Med (1999) 2.47

Recommendations for the management of patients with unruptured intracranial aneurysms: A Statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2000) 2.41

Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke (1999) 2.28

Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg (1993) 2.22

Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators. Stroke (1999) 2.21

A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity. Stroke (2001) 2.16

Factors associated with career longevity in residency-trained emergency physicians. Ann Emerg Med (1992) 2.08

Hukou and non-hukou migrations in China: comparisons and contrasts. Int J Popul Geogr (2000) 2.06

Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer. J Nucl Med (1997) 2.05

Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol (1996) 2.05

Thrombolytic therapy for cerebral infarction. Acad Emerg Med (1996) 1.99

Association of influenza virus matrix protein with ribonucleoproteins. J Virol (1999) 1.95

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke (1992) 1.89

Patients' awareness of stroke signs, symptoms, and risk factors. Stroke (1997) 1.85

Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. Stroke (1999) 1.82

Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system. J Immunol (1999) 1.81

Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol (1993) 1.78

Equipoise among recanalization strategies. Neurology (2010) 1.77

Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood (1997) 1.77

Emergency physicians. Accuracy in the diagnosis of stroke. Stroke (1995) 1.73

Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci U S A (1992) 1.72

Trends and patterns of playground injuries in United States children and adolescents. Ambul Pediatr (2002) 1.68

Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke (1998) 1.64

Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity. Pediatr Blood Cancer (2004) 1.61

Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model. Am J Transplant (2012) 1.61

Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. J Pathol (2001) 1.61

Cardiopulmonary resuscitation and emergency cardiovascular care. Stroke. Ann Emerg Med (2001) 1.57

Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells. Oncogene (2012) 1.55

Effects of erythorbic acid on vitamin C metabolism in young women. Am J Clin Nutr (1996) 1.55

Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques. Nature (1989) 1.55

Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke (1996) 1.55

Oxidant tone regulates RANTES gene expression in airway epithelial cells infected with respiratory syncytial virus. Role in viral-induced interferon regulatory factor activation. J Biol Chem (2001) 1.53

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group. Stroke (1993) 1.53

Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. Stroke (1995) 1.51

Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall. Circulation (2001) 1.50

Frequency and accuracy of prehospital diagnosis of acute stroke. Stroke (1995) 1.49

Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer. J Nucl Med (1992) 1.49

Effects of UDP-glucose addition on the synthesis of mannosyl lipid-linked oligosaccharides by cell-free fibroblast preparations. J Biol Chem (1977) 1.49

Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology (2000) 1.48

Pediatric motor vehicle related injuries in the Navajo Nation: the impact of the 1988 child occupant restraint laws. Inj Prev (2002) 1.45

Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity (1997) 1.44

Capgras' syndrome following minor head trauma. J Clin Psychiatry (1989) 1.44

Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J Mol Biol (2000) 1.44

The winged helix/forkhead transcription factor Foxq1 regulates differentiation of hair in satin mice. Genesis (2001) 1.44

Use of Ephedra-containing products and risk for hemorrhagic stroke. Neurology (2003) 1.43

Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy? Am J Obstet Gynecol (2000) 1.43

Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology (1999) 1.43

Activation of a frizzled-2/beta-adrenergic receptor chimera promotes Wnt signaling and differentiation of mouse F9 teratocarcinoma cells via Galphao and Galphat. Proc Natl Acad Sci U S A (1999) 1.42

Comparison of a 6-hour and 9-hour protocol for evaluation of moderate-to-low risk chest pain patients in an emergency department diagnostic unit. Singapore Med J (2001) 1.41

Measurement of cardiac troponin T is an effective method for predicting complications among emergency department patients with chest pain. Ann Emerg Med (1998) 1.41

Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40

A comparison of performances of consultant surgeons, NCHDs and medical students in a modified HPAT examination. Ir Med J (2010) 1.40

Genomic DNA sequence for human C-reactive protein. J Biol Chem (1985) 1.39

Induction of telomerase activity in fibroblasts from bleomycin-injured lungs. Am J Respir Cell Mol Biol (2000) 1.39

Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue. Obesity (Silver Spring) (2009) 1.39

Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke (2001) 1.38

The distribution of refractory periods influences the dynamics of ventricular fibrillation. Circ Res (2001) 1.38

Purification and properties of a plasmid-encoded 2,4-dichlorophenol hydroxylase. FEBS Lett (1984) 1.38